{"title":"个人健康保险的定价规则:来自Medigap的证据。","authors":"Vilsa E. Curto","doi":"10.1016/j.jhealeco.2023.102785","DOIUrl":null,"url":null,"abstract":"<div><p>I compare two pricing regulations that protect those with health conditions—“community rating,” which requires insurers to charge uniform premiums, and “guaranteed renewal,” which requires insurers to increase future premiums uniformly. Using individual-level Medigap data from 2006–2010, I compare individuals within 25 miles of borders between 3 community rating and 6 guaranteed renewal states. Relative to guaranteed renewal, community rating (with guaranteed issue) leads to a decrease in Medigap enrollment of 9.70 pp (29.7%), or 26.8–33.7% for low-spending conditions (diabetes, heart disease) and 21.9–29.9% for high-spending conditions (cancer, kidney disease); an increase in annual Medigap premiums of $276 (10.1%); a decrease in the likelihood of an earlier purchase of 7.99 pp (50.3%); and an increase in purchase delay of 1.08 years (17.0%).</p></div>","PeriodicalId":50186,"journal":{"name":"Journal of Health Economics","volume":"91 ","pages":"Article 102785"},"PeriodicalIF":3.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pricing regulations in individual health insurance: Evidence from Medigap\",\"authors\":\"Vilsa E. Curto\",\"doi\":\"10.1016/j.jhealeco.2023.102785\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>I compare two pricing regulations that protect those with health conditions—“community rating,” which requires insurers to charge uniform premiums, and “guaranteed renewal,” which requires insurers to increase future premiums uniformly. Using individual-level Medigap data from 2006–2010, I compare individuals within 25 miles of borders between 3 community rating and 6 guaranteed renewal states. Relative to guaranteed renewal, community rating (with guaranteed issue) leads to a decrease in Medigap enrollment of 9.70 pp (29.7%), or 26.8–33.7% for low-spending conditions (diabetes, heart disease) and 21.9–29.9% for high-spending conditions (cancer, kidney disease); an increase in annual Medigap premiums of $276 (10.1%); a decrease in the likelihood of an earlier purchase of 7.99 pp (50.3%); and an increase in purchase delay of 1.08 years (17.0%).</p></div>\",\"PeriodicalId\":50186,\"journal\":{\"name\":\"Journal of Health Economics\",\"volume\":\"91 \",\"pages\":\"Article 102785\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Health Economics\",\"FirstCategoryId\":\"96\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0167629623000620\",\"RegionNum\":2,\"RegionCategory\":\"经济学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ECONOMICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Economics","FirstCategoryId":"96","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167629623000620","RegionNum":2,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
Pricing regulations in individual health insurance: Evidence from Medigap
I compare two pricing regulations that protect those with health conditions—“community rating,” which requires insurers to charge uniform premiums, and “guaranteed renewal,” which requires insurers to increase future premiums uniformly. Using individual-level Medigap data from 2006–2010, I compare individuals within 25 miles of borders between 3 community rating and 6 guaranteed renewal states. Relative to guaranteed renewal, community rating (with guaranteed issue) leads to a decrease in Medigap enrollment of 9.70 pp (29.7%), or 26.8–33.7% for low-spending conditions (diabetes, heart disease) and 21.9–29.9% for high-spending conditions (cancer, kidney disease); an increase in annual Medigap premiums of $276 (10.1%); a decrease in the likelihood of an earlier purchase of 7.99 pp (50.3%); and an increase in purchase delay of 1.08 years (17.0%).
期刊介绍:
This journal seeks articles related to the economics of health and medical care. Its scope will include the following topics:
Production and supply of health services;
Demand and utilization of health services;
Financing of health services;
Determinants of health, including investments in health and risky health behaviors;
Economic consequences of ill-health;
Behavioral models of demanders, suppliers and other health care agencies;
Evaluation of policy interventions that yield economic insights;
Efficiency and distributional aspects of health policy;
and such other topics as the Editors may deem appropriate.